Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Resistance to Immunotherapy in Breast Cancer
Botle Precious Damane
*
, Lorraine Tshegofatso Maebele
, Malose Makgoka
, Dikeledi Hendrika Mokone
, Thanyani Victor Mulaudzi
, Solomon Oladapo Rotimi
, Zodwa Dlamini
*
Corresponding author for this work
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Resistance to Immunotherapy in Breast Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immune Checkpoint Inhibitors
100%
Resistance to Immunotherapy
100%
Toxicity Resistance
33%
Adoptive Cell Transfer
33%
Natural Defenses
33%
Tumor-infiltrating T Cells
33%
Bispecific Antibody
33%
Programmed Cell Death Ligand
33%
Therapeutic Response
33%
Young Black Women
33%
Drug Resistance Mechanisms
33%
Immunotherapeutic Approaches
33%
Thera
33%
Aggressiveness
33%
Programmed Death-ligand 1 (PD-L1)
33%
Triple Negative
33%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
100%
Cell Death
33%
PD-L1
33%
Breast Cancer Screening
33%
Immunology and Microbiology
Cell Death
20%
Bispecific Antibody
20%
Programmed Death-Ligand 1
20%
Immune System
20%
Transfer Cell
20%